Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK1521498 proof-of-concept study in obese adults with overeating behaviors
2009-016663-11Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of GSK-1521498 in obesity (3 arms), sponsored by GSK. Primary endpoint: Change in body weight at Day 28 compared with baseline. Started Jun 2010; status: completed.
02
Drugs
GSK-1521498
03
Conditions
obesity
Beyond the preview
Go deeper on 2009-016663-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016663-11.